OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Harold P. Freeman, Pioneer of Patient Navigation and Health Equity, Dies at 93

Early Bird Registration Is Now Open for the 7th Emirates Oncology Society Annual Conference 2026

FDA Seeks Public Feedback on Regulation of Generative AI-Enabled Medical Devices

Noubar Afeyan: Moderna and Merck Announce Positive Phase 3 Results in Melanoma

Muna Al-Khaifi: Menopausal Symptoms and Quality of Life After Cancer

Oncology News, Insights, Stories by OncoDaily

UICC
Societies

UICC President-elect Election 2026: Meet the Candidates

FDA Grants Fast Track Designation to Nuvation Bio’s Safusidenib for IDH1-Mutant Glioma
Not To Miss

FDA Grants Fast Track Designation to Nuvation Bio’s Safusidenib for IDH1-Mutant Glioma

INTerpath-001 Trial: Personalized mRNA Cancer Vaccine for Melanoma
Immune Oncology

INTerpath-001 Trial: Personalized mRNA Cancer Vaccine for Melanoma

Daffodil Day 2026: 40 Years of Hope Against Cancer

The Carcinogen on Our Plates: Why Kenya Must Treat Aflatoxin Control as Cancer Prevention

GI Cancers Alliance: Could Cancer Vaccines Change the Future of Lynch Syndrome and GI Cancers?

Tedros Adhanom Ghebreyesus: WHO Launches Talent Pipeline for the Next Generation of Public Health Leaders

2026 Early Career Researcher Awardees Receive More Than $1 Million in Funding - PICI

Charles Roberts Named the Next President and CEO of St. Jude Children’s Research Hospital

KENCO and OncoDaily Announce Strategic Partnership

Voices
SIO

Oncology-Specific Training Advances Safe and Effective Acupuncture in Cancer Care - SIO

Welcome Angela Tyre as our Treasurer and Trustee - Oncogene Cancer Research

Bogda Koczwara։ Time to Broaden Our View of What Good Survivorship Care Is and Extend It to Economic Policy Influence

Andrew Davies Appointed Editor-in-Chief of BMJ Supportive and Palliative Care

Stacey Tinianov: We Are Changing the Narrative in Cancer Care with Incredible Patient Advocates

Supporting the Annual Daffodil Day Appeal on Its 40th Anniversary

Advancing Treatment Strategies for EGFR-Mutant NSCLC - Frontiers-Oncology

FDA Approvals
OncoSil

FDA Approves OncoSil Device for Distal Cholangiocarcinoma

FDA Grants Accelerated Approval to Bristol Myers Squibb’s Zenbexus Plus Daratumumab and Hyaluronidase-fihj and Dexamethasone for Multiple Myeloma

FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

OncoDaily 100
100 Influential People in Oncology

100 Influential People in Oncology 2026 – Nominations are Open!

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Celebrities and Cancer

OncoCalendar

Target Engagement and AutoTSA in Small Molecule Drug Discovery - Oncode Accelerator

Oncode Accelerator

06 Oct
Small Molecule Drug Discovery

The “Including Older Adults in Cancer Research: Perspectives Across the Trial Spectrum” Webinar

International Society of Geriatric Oncology (SIOG)

24 Sep
Adults in Cancer Research

Advancing Bioequivalence Frameworks for Inhalation Drug Products

U.S. Food and Drug Administration (FDA)

14 Oct
Advancing Bioequivalence Frameworks

The 2026 AAADV Workshop

AAADV Workshop Foundation

05 Nov
AAADV Workshop

Gene Regulation of Latino-Associated B-ALL SNPs and CAR-T Resistance in Heme Malignancies - Resonance

Acute Leukemia Research and Care Network (ALRCaN)

21 Aug
Gene Regulation

Immune-oncology
INTerpath-001 Trial: Personalized mRNA Cancer Vaccine for Melanoma

INTerpath-001 Trial: Personalized mRNA Cancer Vaccine for Melanoma

Tumor Mutational Burden in Immunotherapy: Why TMB Is More Than a Number

CheckMate 77T study: Can ctDNA Predict Response to Perioperative Immunotherapy in NSCLC?

PIVOTAL Trial: Neoadjuvant Intralesional Immunotherapy in Melanoma

Hypoxia and Immunotherapy Resistance: Can HIF Targeting Improve Response?

In Vivo CAR-T Cell Therapy: Clinical Proof of Concept and the Rising Role of AI

Outpatient Bispecific Antibodies: Considerations for Step-Up Dosing, CRS, and ICANS

Gastrointestinal-Oncology
ESMO Guide

ESMO Clinical Practice Guideline Express Update: Daraxonrasib for Metastatic Pancreatic Cancer

GI Cancers Alliance: Could Cancer Vaccines Change the Future of Lynch Syndrome and GI Cancers?

FDA Grants HDE Approval to OncoSil for Distal Cholangiocarcinoma

PLATFORM: Maintenance Rucaparib in Advanced HER2-Negative Esophagogastric Adenocarcinoma

10 Must-Read Posts In GI Oncology This Week

5 Messages Shaping GI Oncology After ESMO GI 2026: Highlighted by Maria Maddalena Laterza

CAVE and CAVE-2 GOIM Studies: Predictive biomarkers for Cetuximab-Based Rechallenge in mCRC

Breast-Oncology
Neo-CheckRay

Neo-CheckRay: iSBRT and Durvalumab in High-Risk ER+/HER2− Breast Cancer

HER2DX in Early HER2-Positive Breast Cancer: Toward Biology-Guided Treatment Intensity

Breast Cancer in 2026: Molecular Interception, MRD, ADC Sequencing and De-Escalation

Tissue-Free ctDNA Detects MRD Before TNBC Recurrence

Rare Triple-Negative Breast Cancer Is Not One Disease

Oral SERDs in Breast Cancer: Powerful Shift From Rescue to Platform Therapy

Rb-Driven Transcription Reveals a CDK4/6 Paradox in Breast Cancer

Lung-Oncology
RAS-Mediated Resistance

RAS-Mediated Resistance Emerges Across Oncogene-Driven NSCLC

CheckMate 77T: ctDNA Clearance and MRD Refine Risk After Perioperative Nivolumab

DESTINY-Lung04: Enhertu Improves First-Line PFS in HER2-Mutant NSCLC

REZILIENT3 Trial: Major Positive Phase 3 Result in Exon 20 NSCLC

SYS6010 Shows Encouraging Activity Across Pretreated NSCLC

Rilvegostomig NSCLC: 5 Major Promising Findings From ARTEMIDE-01

Air Pollution and Lung Cancer: Critical Metabolic Clues

Oncology Tech
Replimune Tudriqev

Third Time's the Charm: FDA Approves Replimune's Tudriqev (RP1) for Advanced Melanoma

AstraZeneca-Bristol Myers Merger Denied: What It Exposed

Tempus AI to Acquire Personalis in $1.5 Billion Deal, Deepening Its Foothold in Cancer Monitoring

FDA approves GSK's Jideytro for previously treated ROS1-positive NSCLC, the company's first lung cancer clearance

Third Time at the Table: Why Replimune's RP1 Deserves a Real Hearing in Post-PD-1 Melanoma

James Hadfield: Emerging Technologies Aim to Democratize Ultra-Sensitive MRD Testing

The radiopharmaceutical land grab — and the isotope bottleneck no one's pricing in

Hematology
VEXAS Syndrome

VEXAS Syndrome: Is It More a Matter of Inflammation or Hematopoietic Clonality?

Venetoclax + HMA in Newly Diagnosed AML: What Do Real-World Data Show?

BeOne, BeOne Care Foundation and The Max Foundation Renew BRUKINSA Access Partnership for CLL in LMICs

TP53-Mutated MDS: Can New Therapies Change the Prognosis?

Novel Combinations in Myelofibrosis: Advancing Beyond the JAK Inhibitor Backbone

FDA Grants Accelerated Approval to Iberdomide Combination for Multiple Myeloma Based on MRD-Negative CR

Artificial Intelligence and Digital Pathology in Leukemia Diagnosis

Radiotherapy
Radiation Oncology

Call for Papers: “Radiation Oncology in 2026” Special Series

10 Must-Read Posts In Radiotherapy This Week: August 10-16

Mayo Clinic Reports First Clinical Series of Minibeam Radiation Therapy for Superficial Malignancies

TREASURE Trial Raises Safety Concerns Over Thoracic Radiotherapy in ES-SCLC

ESTRO Breast Radiotherapy Target Volumes Prospectively Validated in DBCG Skagen Trial 1

10 Must-Read Posts In Radiotherapy This Week: August 2 -9

DBCG Skagen Trial 1 Validates ESTRO Target Volume Guidelines in Early Breast Cancer

OncoDaily TV
Petra Jankowska

Leading with Humanity in Modern Oncology: Dr. Petra Jankowska

Princess Dina

Episode 18: Global Health Dialogues with Princess Dina and Dr Urvi Shah

Empowering Oncologist

Empowering Oncologists: How to Fight Burnout? Dr. Mimi Knoll

Dr. C.S. Pramesh

The Power of Collaboration in Fighting Cancer: Dr. C.S. Pramesh

Tommy Bramley

Making Innovative Oncology Therapies Accessable for All Patients: Tommy Bramley

Rolando Camacho

Beyond the Policy Paper: Turning Cancer Plans into Real Impact: Dr. Rolando Camacho

Nirmala Bhoo-Pathy

Nirmala Bhoo-Pathy: How to Translate Scientific Breakthroughs into Real-world Benefits

The Man Who Built Elekta: Larry Leksell

The Man Who Built Elekta: Larry Leksell

Empowering Oncologists: Why is Patient Navigation Critically Important in Cancer Care

Empowering Oncologists: Why is Patient Navigation Critically Important in Cancer Care

How One Doctor Helped Transform Cancer Care in New Zealand: Dr. Christopher Jackson

How One Doctor Helped Transform Cancer Care in New Zealand: Dr. Christopher Jackson

World Health Voices

Is US Still a WHO Member? World Health Voices Interview with Prof. Lawrence O. Gostin

Antonio Jimenez (2)

Antonio Jimenez Jimenez: A Powerful Reminder of Why NMDP Work Matters

Not To Miss
AAADV

AAADV 2026: Where the Future of Cancer Drug Development Will Be Debated

FDA Grants Fast Track Designation to Nuvation Bio’s Safusidenib for IDH1-Mutant Glioma

FDA Seeks Public Feedback on Regulation of Generative AI-Enabled Medical Devices

FDA Lists More Than 1,500 AI-Enabled Medical Devices as Oncology Applications Expand

Mammo 2026: Global Breast Cancer Leaders to Meet for Two-Day Virtual Congress

Cancer Planners Forum 2026: Strengthening National Cancer Control Plans Worldwide

10 Major Cancer Research Grants Offering $1M+

OncoGrants
Brain Cancer Research

Uncle Kory Foundation Seed Grant Program 2026 for Brain Cancer Research

AI Training

AACR-AstraZeneca Fellowship for Digital Pathology and AI Training 2026

Stand Up To Cancer

Stand Up To Cancer–PNOC DMG Discoveries Challenge Grant 2026

Early Detection and Diagnosis

Cancer Research UK Early Detection and Diagnosis Primer Award 2026

Clinical Research Funding

Cancer Research UK Clinical Research Funding Scheme 2026

Clinical Future Leaders Fellowship

Cancer Research UK Clinical Future Leaders Fellowship 2026

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Michel Ducreux

Michel Ducreux

Oncologists Location Villejuif, France
Robin Zon

Robin Zon

Oncologists Location Cincinnati, USA
Antonio Lázaro Sánchez

Antonio Lázaro Sánchez

Oncologists Location El Palmar, Spain
Mary Gospodarowicz

Mary Gospodarowicz

Oncologists Location Toronto, Canada
Rawad Rihani

Rawad Rihani

Oncologists Location Amman, Jordan
Subhadarsini Mohapatra

Subhadarsini Mohapatra

Oncologists Location Thiruvananthapuram, India
LIdia Schapira

Lidia Schapira

Oncologists Location Stanford, USA
Gregory Kalemkerian

Gregory Kalemkerian

Oncologists Location Ann Arbor, USA

Oncology Drugs
OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

mRNA-4359: Promising Cancer Vaccine, Dose, Administration, and Clinical Trials

BXCL701: Promising Innate Immune Activation, Dose, Administration, And Clinical Trials

NBTXR3: Promising Radioenhancer, Administration, Dose, And Clinical Trials

KT-333: Promising STAT3 Degradation, Dose, Administration, And Clinical Trials

Veliparib: Mechanism, Dose, Administration, And Clinical Trials

Adavosertib: Mechanism, Dose, Administration, And Clinical Trials

OncoDaily Magazine

New Paper Alert
Daniel K. Nomura

Daniel K. Nomura Unlocks a New Way to Target "Undruggable" PAX8 in Ovarian Cancer

Hashim U. Ahmed

Hashim U. Ahmed: Rethinking SBRT vs. MH-IMRT in Prostate Cancer

Qicong Sheng

Qicong Sheng: ADC Cardiotoxicity in Breast Cancer

Anthony Letai

Anthony Letai: 665 Cancer Models Aim to Accelerate the Next Generation of Drug Discovery

Ajay Major

Ajay Major: Epcoritamab Outcomes Decline in Real-World Patients With Aggressive NHL

Hannah Wardill

Hannah Wardill Uncovers Link Between Radiation Mucositis and Cachexia Driver GDF-15

OncoDaily Medical Journal

Oncology Nursing

10.69690/ODMJ-012-0826-7730

Chronic illness trajectory of patients with multiple myeloma derived from health-related quality of life data – an integrative review
Systematic Reviews & Meta Analysis

Public Health

10.69690/ODMJ-002-0726-7335

From Evidence to Impact: Multilevel Strategies for Cancer Prevention in Europe
Reviews

Oncology Nursing

10.69690/ODMJ-011-0626-7610

Major oral hemorrhage after tongue cancer surgery: A case report
Case Reports & Case Series

Lung Cancer

10.69690/ODMJ-001-0626-7958

Evaluation of Intra-Fractional Target Position Variation during Deep Inspiration Breath-Hold (DIBH) Sessions in Lung Stereotactic Body Radiotherapy (SBRT)
Original Research

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports & Case Series

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries